Literature DB >> 15458670

Fronto-orbital advancement with simultaneous LeFort III-distraction.

Alexander C Kubler1, Bernd Speder, Joachim E Zoller.   

Abstract

BACKGROUND: Patients with pronounced forms of craniosynostosis often suffer from hypoplasia of the facial skeleton. Different techniques have been described to correct these malformations consisting mainly of a standardised fronto-orbital advancement to correct the neurocranium followed by a conventional LeFort III-osteotomy for the correction of the viscerocranium several months later. METHOD AND PATIENTS: In order to optimise treatment, these techniques were confined into a one step procedure. This comprised a standard fronto-orbital advancement and a simultaneous LeFort III-osteotomy, followed by distraction of the facial skeleton 7 days later using a rigid external distractor (RED).
RESULTS: Six patients have been treated with excellent functional and cosmetic results and a high rate of patients' satisfaction. Postoperatively, one patient suffered from rhinorrhoea necessitating revision of the base of the skull 7 days later. In a second patient, the RED distractor could not be fixed due to insufficient ossification of the skull 6 months after subtotal craniectomy. In another patient, partial necrosis of the calvarial skin occurred. No other significant adverse events occurred. DISCUSSION: Upto today the LeFort III advancement plus fronto-orbital advancement were always performed intraoperatively in one single step. When applying the distraction technique, the viscerocranium can be transposed much further than by conventional techniques. Beside this, using the external RED distractor, the distraction vector can be modified and adjusted according to clinical progress postoperatively. In addition, the time gap between the operation and start of distraction allows the soft tissues to reattach, probably reducing the risk of ascending infections.
CONCLUSION: The combination of fronto-orbital advancement and LeFort III advancement by distraction can optimise the clinical outcome and lower the risk of ascending infections.

Entities:  

Mesh:

Year:  2004        PMID: 15458670     DOI: 10.1016/j.jcms.2004.04.009

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  7 in total

1.  Guideline for Care of Patients With the Diagnoses of Craniosynostosis: Working Group on Craniosynostosis.

Authors:  Irene M J Mathijssen
Journal:  J Craniofac Surg       Date:  2015-09       Impact factor: 1.046

Review 2.  Distraction osteogenesis in the surgical treatment of craniostenosis: a comparison of internal and external craniofacial distractor devices.

Authors:  S Pelo; G Gasparini; A Di Petrillo; G Tamburrini; C Di Rocco
Journal:  Childs Nerv Syst       Date:  2007-09-18       Impact factor: 1.475

3.  Complications in the surgical treatment of craniosynostosis and craniofacial syndromes: apropos of 306 transcranial procedures.

Authors:  Javier Esparza; José Hinojosa
Journal:  Childs Nerv Syst       Date:  2008-09-04       Impact factor: 1.475

4.  Le Fort III in Syndromic Craniosynostosis: Cost Comparison of Distraction Osteogenesis Versus Single-Stage Internal Fixation Techniques.

Authors:  Adam J Mosa; Elizabeth Zellner; Emily S Ho; Mark D Fisher; John H Phillips; Christopher R Forrest
Journal:  Plast Surg (Oakv)       Date:  2019-03-13       Impact factor: 0.947

5.  Monoblock craniofacial internal distraction in a child with Pfeiffer syndrome: a case report.

Authors:  Jaiho Chung; Dong Ha Park; Soo Han Yoon
Journal:  J Korean Med Sci       Date:  2008-04       Impact factor: 2.153

6.  Reducing the Burden of Care: Multidisciplinary Management of Late-Manifested Crouzon Syndrome-A Case Report.

Authors:  Sarah Achterrath; Teresa Kruse; Julia Neuschulz; Isabelle Graf; Joachim Zöller; Bert Braumann
Journal:  Children (Basel)       Date:  2021-12-03

7.  Evaluation of cephalometric points in midface bone lengthening with the use of a rigid external device in syndromic craniosynostosis patients.

Authors:  Daniel Santos Corrêa Lima; Nivaldo Alonso; Paulo Roberto Pelúcio Câmara; Dov Charles Goldenberg
Journal:  Braz J Otorhinolaryngol       Date:  2009 May-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.